Newtyn Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Newtyn Management’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$770K	–	50
2023 Q2	$770K	Sell	200,000 -53,818	-21%	-$197K	0.18%	38
2023 Q1	$767K	Sell	253,818 -16,182	-6%	-$55.9K	0.15%	62
2022 Q4	$554K	Sell	270,000 -30,000	-10%	-$91.4K	0.11%	61
2022 Q3	$1.04M	Sell	300,000 -10,000	-3%	-$45.5K	0.23%	53
2022 Q2	$1.3M	Buy	+310,000	New	+$732K	0.25%	55

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Newtyn Management's DBTX Position: Q3 2023 in Review

Newtyn Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 200,000 shares — an estimated $770K sold.

Newtyn Management first reported a position in DBTX in Q2 2022 and held it in 5 quarters. The position peaked at $1.3M in Q2 2022. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Newtyn Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Newtyn Management sold 200,000 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $770K.
Newtyn Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Newtyn Management's Decibel Therapeutics, Inc. Common Stock position peaked at $1.3M in Q2 2022.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Newtyn Management's 13F filing for Q3 2023, filed 14 Nov 2023.